Search research articles
Contact Us
Filters
Showing results (831-840 of 842) with videos related to
Page
of 85
Sort By:
Neuron
|
April 23, 2024
Growth hormone promotes myelin repair after chronic hypoxia via triggering pericyte-dependent angiogenesis
Shu-Yu Ren, Yu Xia, Bin Yu, et al.
Iscience
|
August 5, 2025
Integrated omics identifies molecular networks of brain-body interactions of brain injury
Yuan-Hong Deng, Hong Wang, Jia-Hang Zhang, et al.
Journal of Plant Physiology
|
February 5, 2025
A Gln alteration influences leaf morphogenesis by mediating gibberellin levels in tobacco
Qi-Li Mi, Hong-Tao Lv, Fei-Fei Huang, et al.
Neurology
|
October 15, 2021
Association Between Time to Endovascular Therapy and Outcomes in Patients With Acute Basilar Artery Occlusion
Hong Fei Sang, Jun Jie Yuan, Zhong Ming Qiu, et al.
World Journal of Gastroenterology
|
July 31, 2025
Efficacy and safety of triple therapy with vonoprazan for <i>Helicobacter pylori</i> eradication: A multicenter, prospective, randomized controlled trial
Rong-Shuang Han, Jing-Wen Hao, Tong Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 26, 2019
Structure based design of macrocyclic factor XIa inhibitors: Discovery of cyclic P1 linker moieties with improved oral bioavailability
Charles G Clark, Karen A Rossi, James R Corte, et al.
Journal of Medicinal Chemistry
|
May 28, 2020
Discovery of a High Affinity, Orally Bioavailable Macrocyclic FXIa Inhibitor with Antithrombotic Activity in Preclinical Species
Wu Yang, Yufeng Wang, Amy Lai, et al.
Journal of Medicinal Chemistry
|
September 8, 2021
Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic Therapy
Andrew K Dilger, Kumar B Pabbisetty, James R Corte, et al.
Journal of Medicinal Chemistry
|
December 14, 2019
Potent, Orally Bioavailable, and Efficacious Macrocyclic Inhibitors of Factor XIa. Discovery of Pyridine-Based Macrocycles Possessing Phenylazole Carboxamide P1 Groups
James R Corte, Donald J P Pinto, Tianan Fang, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 12, 2014
Identification of 1-{2-[4-chloro-1'-(2,2-dimethylpropyl)-7-hydroxy-1,2-dihydrospiro[indole-3,4'-piperidine]-1-yl]phenyl}-3-{5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-yl}urea, a potent, efficacious and orally bioavailable P2Y(1) antagonist as an antiplatelet agent
Yoon T Jeon, Wu Yang, Jennifer X Qiao, et al.
Page
of 85
Search research articles
Search
Showing results (831-840 of 842) with videos related to
Sort By:
Page
of 85
Neuron
|
April 23, 2024
Growth hormone promotes myelin repair after chronic hypoxia via triggering pericyte-dependent angiogenesis
Shu-Yu Ren, Yu Xia, Bin Yu, et al.
Iscience
|
August 5, 2025
Integrated omics identifies molecular networks of brain-body interactions of brain injury
Yuan-Hong Deng, Hong Wang, Jia-Hang Zhang, et al.
Journal of Plant Physiology
|
February 5, 2025
A Gln alteration influences leaf morphogenesis by mediating gibberellin levels in tobacco
Qi-Li Mi, Hong-Tao Lv, Fei-Fei Huang, et al.
Neurology
|
October 15, 2021
Association Between Time to Endovascular Therapy and Outcomes in Patients With Acute Basilar Artery Occlusion
Hong Fei Sang, Jun Jie Yuan, Zhong Ming Qiu, et al.
World Journal of Gastroenterology
|
July 31, 2025
Efficacy and safety of triple therapy with vonoprazan for <i>Helicobacter pylori</i> eradication: A multicenter, prospective, randomized controlled trial
Rong-Shuang Han, Jing-Wen Hao, Tong Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 26, 2019
Structure based design of macrocyclic factor XIa inhibitors: Discovery of cyclic P1 linker moieties with improved oral bioavailability
Charles G Clark, Karen A Rossi, James R Corte, et al.
Journal of Medicinal Chemistry
|
May 28, 2020
Discovery of a High Affinity, Orally Bioavailable Macrocyclic FXIa Inhibitor with Antithrombotic Activity in Preclinical Species
Wu Yang, Yufeng Wang, Amy Lai, et al.
Journal of Medicinal Chemistry
|
September 8, 2021
Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic Therapy
Andrew K Dilger, Kumar B Pabbisetty, James R Corte, et al.
Journal of Medicinal Chemistry
|
December 14, 2019
Potent, Orally Bioavailable, and Efficacious Macrocyclic Inhibitors of Factor XIa. Discovery of Pyridine-Based Macrocycles Possessing Phenylazole Carboxamide P1 Groups
James R Corte, Donald J P Pinto, Tianan Fang, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 12, 2014
Identification of 1-{2-[4-chloro-1'-(2,2-dimethylpropyl)-7-hydroxy-1,2-dihydrospiro[indole-3,4'-piperidine]-1-yl]phenyl}-3-{5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-yl}urea, a potent, efficacious and orally bioavailable P2Y(1) antagonist as an antiplatelet agent
Yoon T Jeon, Wu Yang, Jennifer X Qiao, et al.
Page
of 85